China – media

Slaughtering Of Hogs to Control African Swine Fever in China

There are several diseases which may not be so harmful to humans, but they can become deadly to other animals. African swine fever is one such example.
- Source: Reuters
- 664
- August 27, 2018
African Swine Fever China Market Views
Blockchain to be the Solution to China’s Vaccine Production Data Problem?

The tech community advocates blockchain as the answer to China’s vaccine production data problem as the news of a new production scam rattles Chinese citizens' faith in vaccines made locally.
- Source: FiercePharma
- 1,303
- August 10, 2018
blockchain China digital health Market Views vaccines
Chinese Farms to Face Emergency Inspections Following Swine Fever Outbreak

Reports of the country’s first African swine fever case in China’s Liaoning province sparked increased inspections at pig farms and markets and beefed up the scrutinizing of hog transportation.
- Source: Reuters
- 1,016
- August 8, 2018
African Swine Fever China Market Views
HitGen and Merck Collaborates For DNA Library Screening

HitGen and Merck have updated their licensing agreement to a full-fledged drug discovery collaboration in order to screen DNA-encoded libraries for new small-molecule assets.
- Source: FierceBiotech
- 1,000
- August 8, 2018
biotech China Company Insight Merck
Clinical Innovations enters China with new Shanghai Subsidiary

Clinical Innovations has launched its new subsidiary in Shanghai to grow in the Chinese labor and delivery market, expanding its global footprint.
- Source: FierceBiotech
- 1,103
- August 2, 2018
China Company Insight medical device
Takeda CEO Aims to Make China Second-Largest Business in Future

Takeda CEO Christophe Weber aspires to make China its second most important market in the long run, accepting it as a major task in the future.
- Source: FiercePharma
- 875
- July 22, 2018
China Market Views Takeda
China Welcomes Indian Drugmakers, as Trade with U.S. Sees Tension

China opens up its pharmaceutical market to its rather hostile neighbor, India while Beijing and Washington have a tiff over President Donald Trump’s renewed warning of added tariffs on Chinese imports worth $200 billion.
- Source: FiercePharma
- 1,047
- July 17, 2018
China India Market Views pharmaceutical drugs
China’s Drastic Reduction in Cancer Drug Price

The newly formed health insurance administration in China intend to deepen discounts on cancer drugs which were already on its National Reimbursement Drug List (NRDL) based on public bidding and procurement based on cancer therapies. In the meantime, officials will start enlisting negotiations for treatments which were not included on the coverage list.
- Source: FiercePharma
- 809
- July 11, 2018
cancer China pharmaceutical drugs Policies
Ddu to Attend CPhI in Shanghai Sharing Insights on International Marketing of the Medical Trade

As China's leading event for the pharmaceutical industry, CPhI China strives to provide a platform for local, regional and international buyers, manufacturers and suppliers to meet, do business and drive research and development in the Chinese pharmaceutical and healthcare industries.
- Source: Ddu
- 2,928
- June 19, 2018
China CPhI Exhibitions and Activities
Chinese Biologics Company to invest $ 60 Million in Massachusetts for Manufacturing Facilities

The new announcement comes amidst the raising trade tension between Beijing and Washington, over the large trade surplus on China and its industrial policies proposed by President Trump.
- Source: Forbes
- 680
- June 12, 2018
China Market Views USA Wuxi Biologics

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.